Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients

Valeria Santini*, Pierre Fenaux, Aristoteles Giagounidis, Uwe Platzbecker, Alan F. List, Torsten Haferlach, Jim Zhong, Chengqing Wu, Konstantinos Mavrommatis, C. L. Beach, Kyle J. MacBeth, Antonio Almeida

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

14 Citations (Scopus)
Original languageEnglish
Pages (from-to)897-900
Number of pages4
JournalLeukemia
Volume35
Issue number3
DOIs
Publication statusPublished - Mar 2021
Externally publishedYes

Cite this